Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do me a favor -someone please
I'd love to see a PR announcing both MAA application accepted and CUSIP change.
Alcatraz?
N. Igma??
In need of a last minute gift? Buy shares of NWBO on sale at a bargain price.
Try 54923
I'd much prefer they get to discovery rather than settle. As you say, it will be in the discovery phase that the puppeteers will be revealed.
Yes, you're absolutely right. But I'll stand by what I just posted. And, just as an aside, I try to thnk about it from the MHRA inspectors' perspective and not a shareholder's perspective.
Simply that the initial inspection was of the manual process and the second inspection will be a follow-up of that. For a moment, think of it as if there were no Flaskworks. That's how I'm looking at it.
And, I'll add something else I've been thinking of in terms of 'for a moment'. For a moment, and I'm addressing this to nervous longs and the undecided, not the detractors at all who have their own reasons for believing their beliefs. If you had never heard of NWBO or DCVax and first came upon it after the JAMA article or lawsuit and had no input from all the FUD, what would you think? Would you think that you just stumbled upon a diamond in the raw? Would you be excited that there is finally hope for the patients with the cancer with the worst prognosis that is going to be effective against all solid tumors, particularly when combined with other approved treatments? We simply have to wade through this muck until SP can move freely. I've been here 12 years. I get impatient, but I'm 100% certain we will prevail.
I don't believe so. Look at the PR. Flaskworks unit is apart from certification. The first MHRA inspections were of the present manual method and I believe, from all I've read, that the final inspection will also be of the manual process. The addition of the approved Flaskworks process, when ity comes, will bolster production capabilities but will not be necessary for MIA of Sawston. All IMO, of course. But, I've been following this very closely.
From the July 6, 2022 PR:
Appreciate your posts
I understand. I was just expanding on your post.
Not going to happen. It's the 'unpleasant discovery' that management is after. That will reveal the puppeteers.
I want to second this view and add that though we still have no way of knowing what the company may release next, there are a couple of things brewing and some likely. Partnership announcement?, Sawston 100% certified?, MAA application submitted/accepted?. The lawsuit may act as a firewall against manipulation when these PRs come. And, as for why they didn't bring the suit prior to May 10, say, I think the MM activity on 5/10 will be a case study in spoofing and will prove to be valuable in spite of the loss of M/C. I'm sure the company has a complete record of each of the 77mm shares that were allegedly traded that day. Data will be Exhibit A. Same for trading post JAMA article.
I'm long 12 years and would love to see justice.
Do you actually think that this stock has anything at all to do with the market?! Come on.
Briiliant!
Todays' Guardian article appears in Google News on my feed. Just a matter of time until word gets around worldwide.
Thanks abc1212! The audio interview with Dr. Liau is great!!
interview
Precisely. Her talk won't be a rerun of the data presented at NYAS.
Thanks, Atl!
Thank you.
I wish him only what he deserves
Thanks will rework on computer rather than phone.
Will look good in stripes
I've had a long association with the PR sector. Like 40+ years long. There are various ways that the company can pitch the article. Two prominent ways are, 'The first effective GBM treatment in 20 years', and, the second, 'The first trial where ECA has been employed'. The PR power of the second is extremely underrated. Finally, the potential end to the barbaric practice of depriving patients in a trial with life-threatening diseases of the treatment just so there could be a comparator is coming to an end. As data bases for diseases grow and are shared, and this is the important part, the need for control groups will be eliminated. What a blessing! If the PR group works it right, there should be a lot of pick up on the article.
Fireman - I agree that the JA in and of itself won't have a huge impact on share price. Add in an effective PR blitz and we should see some movement up. What will get some notice and movement, IMO, will be the PR annoucing the MAA application to MHRA. We're getting close, finally.
Not to mention that 'partnership' would be a non-sequitur.
Then you're ahead of the game. GLTA
I think he said, Blessed are the cheesemakers. I'm sure of it, in fact.
Good work DD!
So the end is finally nigh.
Right. So within 60 days of the acceptance of PIP……. Tick, tick, tick
Short Floo. It’s not about deferral
Like i said, MAA app. Hehe. Bright sunshine and sunglasses
Not for deferral, but mas spo